首页> 外文期刊>Nature protocols erecipes for researchers >In vivo antigen-driven plasmablast enrichment in combination with antigen-specific cell sorting to facilitate the isolation of rare monoclonal antibodies from human B cells
【24h】

In vivo antigen-driven plasmablast enrichment in combination with antigen-specific cell sorting to facilitate the isolation of rare monoclonal antibodies from human B cells

机译:体内抗原驱动的成浆细胞富集与抗原特异性细胞分选相结合,以促进从人B细胞中分离稀有单克隆抗体

获取原文
获取原文并翻译 | 示例
           

摘要

The ability to rapidly generate large panels of antigen-specific human antibodies in a rodent would enable the efficient discovery of novel therapeutically useful antibodies. We have developed a system wherein human antigen-specific antibody–secreting plasmablasts can be enriched in vivo, in a severe combined immunodeficient (SCID)/beige mouse host. The antigen-specific plasmablasts can then be sorted by flow cytometry, enabling single-cell cloning and expression of fully human immunoglobulin-G. By using this technique, we have generated four broadly reactive anti–influenza A antibodies. Therefore, the method described here is useful for the identification of rare functional antibodies. This protocol takes ~1 month to complete, from the time of human vaccination to the cloning of heavy- and light-chain genes. For additional small-scale transient expression, purification and binding analysis, the protocol would take an additional month.
机译:在啮齿动物中快速产生大量抗原特异性人抗体的能力将使得能够有效地发现新颖的治疗上有用的抗体。我们已经开发了一种系统,其中可以在严重的联合免疫缺陷(SCID)/米色小鼠宿主中体内分泌人抗原特异性抗体的浆母细胞丰富。然后可以通过流式细胞术对抗原特异性浆母细胞进行分类,从而实现单细胞克隆和完整人免疫球蛋白-G的表达。通过使用这种技术,我们产生了四种广泛反应的抗A型流感抗体。因此,此处描述的方法可用于鉴定稀有功能性抗体。从人类接种疫苗到克隆重链和轻链基因,此协议大约需要1个月才能完成。对于其他小规模的瞬时表达,纯化和结合分析,该方案将需要一个月的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号